Sara Rodríguez-Mora

946 total citations
40 papers, 620 citations indexed

About

Sara Rodríguez-Mora is a scholar working on Infectious Diseases, Immunology and Virology. According to data from OpenAlex, Sara Rodríguez-Mora has authored 40 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 14 papers in Immunology and 11 papers in Virology. Recurrent topics in Sara Rodríguez-Mora's work include HIV Research and Treatment (11 papers), Immune Cell Function and Interaction (9 papers) and COVID-19 Clinical Research Studies (8 papers). Sara Rodríguez-Mora is often cited by papers focused on HIV Research and Treatment (11 papers), Immune Cell Function and Interaction (9 papers) and COVID-19 Clinical Research Studies (8 papers). Sara Rodríguez-Mora collaborates with scholars based in Spain, United States and France. Sara Rodríguez-Mora's co-authors include Mayte Coiras, María Rosa López‐Huertas, José Alcamı́, Elena Mateos, Juan A. García-Velasco, Alberto Pacheco, Rosario Cerrillo Martín, Montserrat Torres, Vicente Planelles and Mercedes Bermejo and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Sara Rodríguez-Mora

40 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sara Rodríguez-Mora Spain	17	191	169	149	125	114	40	620
Ran Wei China	15	63 0.3×	41 0.2×	267 1.8×	260 2.1×	52 0.5×	36	717
Judith M. Andrews United States	7	51 0.3×	50 0.3×	110 0.7×	82 0.7×	40 0.4×	11	615
Sunhee Lee South Korea	13	63 0.3×	15 0.1×	108 0.7×	109 0.9×	147 1.3×	26	645
Twanda L. Thirkill United States	19	75 0.4×	110 0.7×	231 1.6×	341 2.7×	50 0.4×	32	810
Mina Suzuki Japan	14	88 0.5×	23 0.1×	160 1.1×	120 1.0×	187 1.6×	30	589
Suneil Malik Canada	12	113 0.6×	24 0.1×	127 0.9×	135 1.1×	45 0.4×	13	759
Sorour Khateri Iran	10	43 0.2×	54 0.3×	52 0.3×	96 0.8×	45 0.4×	22	422
Maud Thérésine Luxembourg	5	43 0.2×	32 0.2×	675 4.5×	82 0.7×	32 0.3×	6	824
H. Hetzel Austria	10	50 0.3×	37 0.2×	96 0.6×	146 1.2×	31 0.3×	33	504
Thomas H. Teal United States	14	265 1.4×	15 0.1×	486 3.3×	232 1.9×	38 0.3×	17	968

Countries citing papers authored by Sara Rodríguez-Mora

Since Specialization

Citations

This map shows the geographic impact of Sara Rodríguez-Mora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Rodríguez-Mora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Rodríguez-Mora more than expected).

Fields of papers citing papers by Sara Rodríguez-Mora

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Rodríguez-Mora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Rodríguez-Mora. The network helps show where Sara Rodríguez-Mora may publish in the future.

Co-authorship network of co-authors of Sara Rodríguez-Mora

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Rodríguez-Mora. A scholar is included among the top collaborators of Sara Rodríguez-Mora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Rodríguez-Mora. Sara Rodríguez-Mora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rodríguez-Mora, Sara, Elena Mateos, Miguel Cervero, et al.. (2024). Sustained antiviral response against in vitro HIV-1 infection in peripheral blood mononuclear cells from people with chronic myeloid leukemia treated with ponatinib. Frontiers in Pharmacology. 15. 1426974–1426974. 1 indexed citations

Rodríguez-Mora, Sara, Elena Mateos, Diego Megı́as, et al.. (2024). Dasatinib interferes with HIV-1 proviral integration and the inflammatory potential of monocyte-derived macrophages from people with HIV. Biochemical Pharmacology. 229. 116512–116512. 3 indexed citations

Rodríguez-Mora, Sara, Magdalena Corona, Elena Mateos, et al.. (2023). Regular Humoral and Cellular Immune Responses in Individuals with Chronic Myeloid Leukemia Who Received a Full Vaccination Schedule against COVID-19. Cancers. 15(20). 5066–5066. 1 indexed citations

Corona, Magdalena, Montserrat Torres, Adolfo Sáez, et al.. (2023). Sustained Cytotoxic Response of Peripheral Blood Mononuclear Cells from Unvaccinated Individuals Admitted to the ICU Due to Critical COVID-19 Is Essential to Avoid a Fatal Outcome. International Journal of Environmental Research and Public Health. 20(3). 1947–1947. 1 indexed citations

Torres, Montserrat, Magdalena Corona, Sara Rodríguez-Mora, et al.. (2022). Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster. Cancers. 14(22). 5537–5537. 1 indexed citations

Rodríguez-Mora, Sara, Magdalena Corona, Montserrat Torres, et al.. (2022). Early Cellular and Humoral Responses Developed in Oncohematological Patients after Vaccination with One Dose against COVID-19. Journal of Clinical Medicine. 11(10). 2803–2803. 5 indexed citations

Rodríguez-Mora, Sara, Javier García‐Pérez, Magdalena Corona, et al.. (2022). Strong Cellular Immune Response, but Not Humoral, against SARS-CoV-2 in Oncohematological Patients with Autologous Stem Cell Transplantation after Natural Infection. Journal of Clinical Medicine. 11(8). 2137–2137. 2 indexed citations

Galán, Miguel Á., Montserrat Torres, Antonio J. Martín-Galiano, et al.. (2022). Association between HLA-C alleles and COVID-19 severity in a pilot study with a Spanish Mediterranean Caucasian cohort. PLoS ONE. 17(8). e0272867–e0272867. 13 indexed citations

Galán, Miguel Á., Elena Mateos, Vicente Planelles, et al.. (2022). Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals With Long-COVID: Identification of Diagnostic Biomarkers. Frontiers in Immunology. 13. 848886–848886. 59 indexed citations

10.

Díez‐Fuertes, Francisco, María Rosa López‐Huertas, Javier García‐Pérez, et al.. (2022). Transcriptomic Evidence of the Immune Response Activation in Individuals With Limb Girdle Muscular Dystrophy Dominant 2 (LGMDD2) Contributes to Resistance to HIV-1 Infection. Frontiers in Cell and Developmental Biology. 10. 839813–839813. 2 indexed citations

11.

Luna, Alejandro, Miguel Á. Galán, Sara Rodríguez-Mora, et al.. (2020). Identification of Immunological Parameters as Predictive Biomarkers of Relapse in Patients with Chronic Myeloid Leukemia on Treatment-Free Remission. Journal of Clinical Medicine. 10(1). 42–42. 17 indexed citations

12.

Rodríguez-Mora, Sara, Javier García‐Pérez, Mercedes Bermejo, et al.. (2019). The mutation of Transportin 3 gene that causes limb girdle muscular dystrophy 1F induces protection against HIV-1 infection. PLoS Pathogens. 15(8). e1007958–e1007958. 17 indexed citations

13.

Rodríguez-Mora, Sara, Adam M. Spivak, María Rosa López‐Huertas, et al.. (2019). Tyrosine Kinase Inhibition: a New Perspective in the Fight against HIV. Current HIV/AIDS Reports. 16(5). 414–422. 7 indexed citations

14.

López‐Huertas, María Rosa, Nadia Madrid-Elena, Carolina Gutiérrez, et al.. (2017). The CCR5-antagonist Maraviroc reverses HIV-1 latency in vitro alone or in combination with the PKC-agonist Bryostatin-1. Scientific Reports. 7(1). 2385–2385. 40 indexed citations

15.

Bermejo, Mercedes, María Rosa López‐Huertas, Javier García‐Pérez, et al.. (2016). Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells. Biochemical Pharmacology. 106. 30–45. 46 indexed citations

16.

Bermejo, Mercedes, María Rosa López‐Huertas, Joe Hedgpeth, et al.. (2015). Analysis of protein kinase C theta inhibitors for the control of HIV-1 replication in human CD4+ T cells reveals an effect on retrotranscription in addition to viral transcription. Biochemical Pharmacology. 94(4). 241–256. 22 indexed citations

17.

García-Velasco, Juan A., Sara Rodríguez-Mora, David Agudo, et al.. (2012). FSH receptor in vitro modulation by testosterone and hCG in human luteinized granulosa cells. European Journal of Obstetrics & Gynecology and Reproductive Biology. 165(2). 259–264. 16 indexed citations

18.

García-Velasco, Juan A., et al.. (2009). Decreased concentrations of AMH in follicular fluid of women with endometriosis: A hypothetical newmarker of oocyte quality. Journal of Endometriosis and Pelvic Pain Disorders. 1(1). 52–56. 1 indexed citations

19.

Martín, Rosario Cerrillo, et al.. (2008). Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus hCG: a rationale for OHSS reduction. Fertility and Sterility. 91(4). 1526–1528. 49 indexed citations

20.

Rodríguez-Mora, Sara, et al.. (1987). Anticuerpos contra Aspergillus fumigatus en asmáticos atópicos. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact